RT Journal Article
SR Electronic
T1 Artificial intelligence-enabled analysis of UK and US public attitudes on Facebook and Twitter towards COVID-19 vaccinations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.08.20246231
DO 10.1101/2020.12.08.20246231
A1 Amir Hussain
A1 Ahsen Tahir
A1 Zain Hussain
A1 Zakariya Sheikh
A1 Mandar Gogate
A1 Kia Dashtipour
A1 Azhar Ali
A1 Aziz Sheikh
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.08.20246231.abstract
AB Background Global efforts towards the development and deployment of a vaccine for SARS-CoV-2 are rapidly advancing. We developed and applied an artificial-intelligence (AI)-based approach to analyse social-media public sentiment in the UK and the US towards COVID-19 vaccinations, to understand public attitude and identify topics of concern.Methods Over 300,000 social-media posts related to COVID-19 vaccinations were extracted, including 23,571 Facebook-posts from the UK and 144,864 from the US, along with 40,268 tweets from the UK and 98,385 from the US respectively, from 1st March - 22nd November 2020. We used natural language processing and deep learning based techniques to predict average sentiments, sentiment trends and topics of discussion. These were analysed longitudinally and geo-spatially, and a manual reading of randomly selected posts around points of interest helped identify underlying themes and validated insights from the analysis.Results We found overall averaged positive, negative and neutral sentiment in the UK to be 58%, 22% and 17%, compared to 56%, 24% and 18% in the US, respectively. Public optimism over vaccine development, effectiveness and trials as well as concerns over safety, economic viability and corporation control were identified. We compared our findings to national surveys in both countries and found them to correlate broadly.Conclusions AI-enabled social-media analysis should be considered for adoption by institutions and governments, alongside surveys and other conventional methods of assessing public attitude. This could enable real-time assessment, at scale, of public confidence and trust in COVID-19 vaccinations, help address concerns of vaccine-sceptics and develop more effective policies and communication strategies to maximise uptake.Competing Interest StatementAS is a member of the Scottish Governments Chief Medical Officers COVID-19 Advisory Group and the UK Governments New and Emerging Respiratory Virus Threats (NERVTAG) Risk Stratification Subgroup. This work does not represent the views of the Scottish or UK Governments.Clinical TrialThis study was not a clinical trial.Funding StatementThe study reported here is funded by the Scottish Government Chief Scientist Office under its COVID-19 priority research programme (grant ref. COV/NAP/20/07) and is jointly led by co-Principal Investigators: AH and AS. AS is supported by BREATHE - The Health Data Research (HDR) Hub for Respiratory Health (MC_PC_19004), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through HDR UK. AH is supported by the UK Governments Engineering and Physical Sciences Research Council (EPSRC) grants (Ref. EP/T021063/1, EP/T024917/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We conducted a thorough assessment of the privacy risk to individuals posed by our research to ensure compliance with relevant sections of the General Data Protection Regulation (GDPR). Further we have striven to comply with best practices for user protection ensuring no non-public material is included in our dataset.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code for data analysis and figures generation are openly available for reproducibility and transparent analysis. Our Twitter dataset was obtained using the publicly available Twitter API. Our Facebook dataset was obtained using the CrowdTangle platform, for which access must be requested from the organisation. All analysis was carried out in Python. Our code can be used as a reference for conducting similar studies. Due to the computationally expensive nature of the code, we recommend using a high performance computing resource. https://gitlab.com/covid19aidashboard/covid-vaccination/ BERTBidirectional Encoder Representations from TransformersCOVID-19coronavirus diseaseDLDeep LearningMLMachine LearningNLPNatural Language ProcessingPp-valueVADERValence Aware Dictionary and sEntiment Reasoner